Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2024-08-15 00:00:00 ET · period of report 2024-08-13 · accession 0001683168-24-005773 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-15 | 2024-08-13 | PHIO | Infarinato Robert M. | VP, CFO | A - Grant | $0.00 | +8,000 | 8,000 | New | $0 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, $0.0001 par value | 2024-08-13 | A | A | 8,000 | $0.00 | 8,000 | D | — | — | (F1) Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments commencing on the first anniversary of the grant date. (F2) Includes shares of common stock underlying unvested restricted stock units. |